A detailed history of Smartleaf Asset Management LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 112 shares of SRPT stock, worth $13,198. This represents 0.0% of its overall portfolio holdings.

Number of Shares
112
Previous 55 103.64%
Holding current value
$13,198
Previous $5.38 Million 229.01%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$113.33 - $163.85 $6,459 - $9,339
57 Added 103.64%
112 $17.7 Million
Q1 2024

Oct 07, 2024

SELL
$93.7 - $141.53 $5,340 - $8,067
-57 Reduced 50.89%
55 $7.16 Million
Q4 2023

Feb 12, 2024

BUY
$67.31 - $124.76 $3,702 - $6,861
55 New
55 $5.38 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.3B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Smartleaf Asset Management LLC Portfolio

Follow Smartleaf Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smartleaf Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smartleaf Asset Management LLC with notifications on news.